Which of the following anticonvulsants do not routinely require therapeutic drug level monitoring?

Combined oral contraceptives (COCs) contain estrogen and progestin components that influence both contraceptive efficacy and side effect profiles. Androgenic side effects such as acne and weight changes are commonly associated with second-generation progestins due to their higher androgen receptor activity. Selecting an alternative formulation often involves switching to a progestin with lower androgenic activity while maintaining adequate cycle control and contraceptive effectiveness. The goal is to improve tolerability without compromising safety or efficacy.

Rationale:
A. Androgenic side effects from Levonorgestrel do not reliably resolve over time in many patients, especially when related to intrinsic androgen receptor activity. Waiting without changing therapy may prolong bothersome acne and weight concerns, reducing adherence and satisfaction. Clinical improvement is more likely achieved through changing the progestin component rather than expecting spontaneous resolution.

B. Lowering the ethinyl estradiol (EE) dose while continuing Levonorgestrel may reduce estrogen-related side effects but does not significantly address androgenic effects such as acne. In some cases, reducing estrogen may worsen breakthrough bleeding without improving acne. Therefore, this option does not effectively target the patient’s main concern.

C. A progesterone-only contraceptive such as Norethindrone is not appropriate in this scenario because it eliminates estrogen, which plays a role in cycle regulation and acne control. Progestin-only pills can also cause irregular bleeding and may not improve androgenic side effects. This option does not optimize both safety and symptom management for the patient’s presentation.

D. Switching to a formulation containing Desogestrel while maintaining EE 30mcg is the best option because third-generation progestins have lower androgenic activity compared to levonorgestrel. This change is more likely to improve acne and weight-related concerns while maintaining good cycle control and contraceptive efficacy. It balances symptom management with continued reliable contraception.

Severe cystic acne is a deep, inflammatory form of acne vulgaris that can lead to scarring and significant psychosocial distress if not properly managed. Isotretinoin (Accutane) is one of the most effective treatments for refractory severe acne but requires strict monitoring due to its teratogenicity and potential systemic side effects. Initiation of this medication involves specialized prescribing programs and careful risk evaluation. Referral to a specialist ensures safe and appropriate management.

Rationale:
A. Obtaining a thyroid stimulating hormone (TSH) level is not a prerequisite for initiating Isotretinoin (Accutane) therapy. While baseline labs such as liver function tests and lipid profiles are commonly required, thyroid function testing is not routinely indicated. Additionally, isotretinoin initiation requires structured monitoring and prescribing under appropriate protocols, typically managed by dermatology.

B. Referral to a dermatologist is the most appropriate action because Isotretinoin (Accutane) requires specialized oversight due to its high-risk profile, including severe teratogenicity and potential psychiatric and metabolic side effects. Dermatologists are trained to manage enrollment in risk management programs, monitor laboratory values, and ensure safe use, especially in reproductive-age females.

C. Stating that isotretinoin is contraindicated in all females is incorrect because it is not absolutely contraindicated; rather, it is strictly controlled in females of reproductive potential. With proper enrollment in pregnancy prevention programs and adherence to contraception requirements, it can be safely prescribed. Oral tetracyclines are not appropriate substitutes for severe cystic acne and are also contraindicated in pregnancy.

D. Severe cystic acne does require treatment escalation when first-line therapies fail, as untreated disease can result in permanent scarring and significant psychological impact. Minimizing the condition as “typical” ignores the progressive and potentially disfiguring nature of severe acne. Escalation to advanced therapies such as Isotretinoin (Accutane) is standard of care when indicated.